Insulin therapy for diabetes
Pro Research Analysisby 
Searched over 200M research papers
Insulin Therapy for Diabetes: Indications and Patient Populations
Insulin therapy is essential for all patients with type 1 diabetes, as their bodies cannot produce insulin, making it a life-saving treatment for this group Silver2018Azad2013Home2025+1 MORE. For people with type 2 diabetes, insulin is often introduced when oral medications and lifestyle changes are no longer effective, or when blood sugar levels are very high (HbA1c ≥10% or blood glucose ≥300 mg/dL), during acute illness, surgery, pregnancy, or when there is glucose toxicity Silver2018Campbell2002Home2014+2 MORE. Insulin is also used in special cases such as pancreoprivic diabetes, in patients with significantly impaired renal function, and in hospitalized patients .
Types of Insulin and Regimens: Basal, Bolus, and Combination Approaches
Insulin regimens are designed to mimic the body’s natural insulin secretion, which includes a steady basal level and surges at mealtimes Silver2018Campbell2002Home2025. For type 1 diabetes, multiple daily injections of both basal (long-acting) and bolus (short- or rapid-acting) insulin are standard, often supported by technologies like insulin pumps and continuous glucose monitoring Silver2018Home2025. In type 2 diabetes, insulin therapy typically starts with a basal insulin, such as insulin glargine or degludec, and may be intensified by adding mealtime (bolus) insulin or premixed formulations if glycemic targets are not met Silver2018Campbell2002Home2014+3 MORE.
Newer insulin analogues, including long-acting and rapid-acting types, offer more flexibility and can reduce the risk of hypoglycemia compared to older human insulins Silver2018Campbell2002Cahn2015+2 MORE. Weekly insulins and fixed-ratio combinations with GLP-1 receptor agonists are emerging options that may improve adherence and glycemic control Cahn2015Tsai2024Mathieu2021.
Glycemic Targets and Monitoring in Insulin Therapy
The goal of insulin therapy is to maintain blood glucose levels as close to the normal range as safely possible, minimizing the risk of both hyperglycemia and hypoglycemia Swinnen2010Silver2018Campbell2002+1 MORE. For most adults, an HbA1c target of <7.0% is recommended, balancing the benefits of tight control with the risks of hypoglycemia, especially in older adults or those with comorbidities Swinnen2010Silver2018Home2014. Blood glucose monitoring, including self-monitoring and continuous glucose monitoring, is crucial for effective insulin dose adjustment and safety Silver2018Home2025Tsai2024.
Safety, Side Effects, and Special Considerations
While insulin therapy is effective, it carries risks such as hypoglycemia and weight gain, particularly with intensive regimens Swinnen2010Home2014Cahn2015+2 MORE. Newer insulins and delivery methods aim to reduce these risks Cahn2015Tsai2024. Complications like lipohypertrophy (thickening of the skin at injection sites) can be minimized by rotating injection sites and using shorter needles . Rarely, insulin allergy or anti-insulin antibodies can cause severe reactions . There is some concern about a possible increased risk of certain cancers with insulin use, but more research is needed to confirm these findings .
Advances and Future Directions in Insulin Therapy
Insulin therapy has evolved significantly, with the development of insulin analogues, biosimilars, and advanced delivery devices such as insulin pumps and continuous glucose monitors Cahn2015Home2025Tsai2024+1 MORE. Research continues into once-weekly insulins, oral and glucose-dependent insulins, and combination therapies to further individualize treatment and improve patient outcomes Cahn2015Tsai2024Mathieu2021. Despite these advances, insulin remains central to diabetes management, especially for those with type 1 diabetes and many with type 2 diabetes .
Conclusion
Insulin therapy is a cornerstone in the management of both type 1 and type 2 diabetes. It is essential for type 1 diabetes and becomes necessary for many with type 2 diabetes as the disease progresses. Advances in insulin formulations and delivery methods have improved safety, flexibility, and patient adherence. Ongoing research aims to further individualize therapy and reduce the burden of diabetes complications, ensuring insulin remains a vital tool in diabetes care Swinnen2010Silver2018Campbell2002+5 MORE.
Sources and full results
Most relevant research papers on this topic